Table 2.

Results of analyses of risk of first stroke in homozygous sickle cell disease (SS) patients: Data from the Cooperative Study of Sickle Cell Disease (CSSCD).

A. Infarctive Stroke
Final multivariate model: Five predictors significant at p < 0.05
PredictorRelative Risk95% CIp value
Prior transient ischemic attack (TIA) 56.0 (12.0, 285) < 0.001 
Baseline Hb (g/dL) decrease 1.85 per 1 g/dL (1.32, 2.59) < 0.001 
Acute chest syndrome within previous two weeks 7.03 (1.85, 26.7) 0.001 
Acute chest syndrome rate 2.39 per event /yr (1.27, 4.48) 0.005 
Systolic blood pressure rise 1.31 per 10 mm Hg (1.03, 1.67) 0.033 
A. Infarctive Stroke
Final multivariate model: Five predictors significant at p < 0.05
PredictorRelative Risk95% CIp value
Prior transient ischemic attack (TIA) 56.0 (12.0, 285) < 0.001 
Baseline Hb (g/dL) decrease 1.85 per 1 g/dL (1.32, 2.59) < 0.001 
Acute chest syndrome within previous two weeks 7.03 (1.85, 26.7) 0.001 
Acute chest syndrome rate 2.39 per event /yr (1.27, 4.48) 0.005 
Systolic blood pressure rise 1.31 per 10 mm Hg (1.03, 1.67) 0.033 
B. Hemorrhagic Stroke
Final multivariate model: Two predictors significant at p < 0.05
PredictorRelative Risk95% CIp value
Abbreviations: CI, confidence interval Source: Ohene-Frempong et al. Blood. 1998;91:288-294 
Baseline Hb (g/dL) decrease 1.61 per 1 g/dL (1.11, 2.35) 0.013 
WBC (1x109/L) increase 1.94 per 5x109/L (1.73, 2.18) 0.026 
B. Hemorrhagic Stroke
Final multivariate model: Two predictors significant at p < 0.05
PredictorRelative Risk95% CIp value
Abbreviations: CI, confidence interval Source: Ohene-Frempong et al. Blood. 1998;91:288-294 
Baseline Hb (g/dL) decrease 1.61 per 1 g/dL (1.11, 2.35) 0.013 
WBC (1x109/L) increase 1.94 per 5x109/L (1.73, 2.18) 0.026 
Close Modal

or Create an Account

Close Modal
Close Modal